Raw material costs: Fluctuations in the prices of key ingredients used in pharmaceutical manufacturing directly impact Orchid Pharma's production expenses and profitability, affecting investor sentiment.

Regulatory changes: New drug approvals, patent expirations, and changes in pharmaceutical regulations can significantly alter Orchid Pharma's market access and revenue streams, influencing stock valuation.

Competition: The presence and actions of competitors, including pricing strategies and new product launches, can affect Orchid Pharma's market share and sales, impacting investor confidence.

Financial performance: Orchid Pharma's revenue, profitability, debt levels, and cash flow generation are closely monitored by investors, with strong financial results typically leading to higher stock prices.

Economic conditions: Macroeconomic factors such as inflation, interest rates, and currency exchange rates can influence Orchid Pharma's operating environment and profitability, affecting investor appetite for the stock.